VRSN Insider Transaction: Indelicarto Sells 501 Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
Thomas C. Indelicarto, EVP, General Counsel & Secretary of VeriSign, Inc. (VRSN), reported an open-market sale of 501 shares of VeriSign common stock on 09/02/2025 at a reported price of $270.46 per share. After the sale, he beneficially owned 35,692.2718 shares. The filing indicates the sale was made pursuant to a written plan intended to satisfy the Rule 10b5-1 affirmative defense. The filing also notes the acquisition of 49.4107 dividend-equivalent restricted stock units on 08/27/2025 relating to previously granted restricted stock units under the company’s equity incentive plan.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider sold a small block of shares under a 10b5-1 plan; holdings remain substantial and the transaction appears routine.
The sale of 501 shares at $270.46 reduces the reporting person’s stake modestly relative to the remaining 35,692.2718 shares held. The explicit use of a 10b5-1 plan reduces the likelihood the transaction was based on undisclosed material information. The additional note of 49.4107 dividend-equivalent RSUs acquired reflects routine equity compensation vesting rather than a new grant. Overall, this filing is informational and not likely material to VeriSign’s valuation on its own.
TL;DR: Proper disclosure and 10b5-1 treatment indicate governance-compliant insider activity with limited investor impact.
The reporting shows timely disclosure, manual signature, and explicit Rule 10b5-1 plan usage, which are good governance practices. The sale volume (501 shares) is small versus total holdings and does not signal a significant change in insider exposure. The record of dividend-equivalent RSUs being credited is a standard administrative item tied to prior awards.